Institutional investors hold a majority ownership of AMGN through the 82.48% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 1.4 Million shares of Amgen
JANUS CAPITAL MANAGEMENT LLC Bought 824.4 Thousand shares of Amgen
THE VANGUARD GROUP, INC. Bought 772.6 Thousand shares of Amgen